IRIS
CIPRANDI, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.056
EU - Europa 509
AS - Asia 294
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
SA - Sud America 1
Totale 1.863
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.050
IE - Irlanda 320
CN - Cina 241
DE - Germania 53
FI - Finlandia 53
SE - Svezia 31
VN - Vietnam 28
IT - Italia 26
IN - India 15
CA - Canada 6
BE - Belgio 5
GB - Regno Unito 5
NL - Olanda 4
UA - Ucraina 3
LA - Repubblica Popolare Democratica del Laos 2
PS - Palestinian Territory 2
RO - Romania 2
RU - Federazione Russa 2
AP - ???statistics.table.value.countryCode.AP??? 1
AT - Austria 1
AU - Australia 1
BR - Brasile 1
EU - Europa 1
FR - Francia 1
GR - Grecia 1
HU - Ungheria 1
IR - Iran 1
JP - Giappone 1
PH - Filippine 1
PT - Portogallo 1
SA - Arabia Saudita 1
SG - Singapore 1
UZ - Uzbekistan 1
Totale 1.863
Salva come PNG Salva come JPEG
Città #
Dublin 320
Chandler 273
Ashburn 138
Princeton 66
Beijing 65
Lawrence 60
Medford 53
Helsinki 49
Nanjing 42
Wilmington 40
Dong Ket 28
Shanghai 28
Ann Arbor 24
Nanchang 22
Dearborn 21
Washington 19
Changsha 16
Hebei 16
Jacksonville 14
New York 14
Hangzhou 13
Redwood City 12
Seattle 11
Shenyang 11
Los Angeles 10
Pune 8
Tianjin 8
Fairfield 6
Toronto 6
Brussels 5
Cambridge 5
Norwalk 5
Nuremberg 5
Berlin 4
Hefei 4
Milan 4
Woodbridge 4
Frankfurt am Main 3
Gunzenhausen 3
Jiaxing 3
Sabzi Mandi 3
San Francisco 3
Shenzhen 3
Wuhan 3
Bologna 2
Cosenza 2
Des Moines 2
Falkenstein 2
Kunming 2
Las Vegas 2
Orange 2
Philadelphia 2
Serra 2
Ardabil 1
Arezzo 1
Boardman 1
Borås 1
Caserta 1
Fayetteville 1
Galati 1
Genoa 1
Kemerovo 1
Lincoln 1
Mainz 1
Melbourne 1
Mountain View 1
Pavia 1
Redmond 1
Saint-gervais-les-bains 1
Sindelfingen 1
Singapore 1
Teverola 1
Tokyo 1
Trumbull 1
Walnut 1
Zhengzhou 1
Totale 1.491
Salva come PNG Salva come JPEG
Nome #
Cross reactivity between recombinant parvalbumin of carp and cod and recombinant grass molecules 75
Adenoids and clinical symptoms: Epidemiology of a cohort of 795 pediatric patients 55
Allergen-specific immunoglobulin E and allergic rhinitis severity 54
Low-dose multicomponent medication modulates humoral and cellular immune response in an ex-vivo study on children subjected to adenoid surgery 53
Phleum pratense molecular pattern across Italy 50
Asthma endotyping and biomarkers in childhood asthma 49
Severe asthma in children: Current goals and unmet needs 48
A polycentric, randomized, double blind, parallel-group, placebo-controlled study on Lertal®, a multicomponent nutraceutical, as add-on treatment in children with allergic rhinoconjunctivitis: phase I during active treatment 45
Current and emerging biologic therapies for allergic rhinitis and chronic rhinosinusitis 44
Allergen immunotherapy in children and adolescents with respiratory diseases 44
Anxiety/depression changes are associated with improved asthma control perception in asthmatic adolescents after adequate management 41
Biomarkers of immunotherapy response in patients with allergic rhinitis 40
Dupilumab to Treat Type 2 Inflammatory Diseases in Children and Adolescents 39
Pentraxin 3 and D-dimer in children with asthma: A real-world study 38
Anxiety and Depression in Adolescents with Severe Asthma and in Their Parents: Preliminary Results after 1 Year of Treatment 38
Immunotherapy and asthma in children 37
Asthma control in children and adolescents: a study in clinical practice 37
Allergen Immunotherapy in Pediatric Asthma: A Pragmatic Point of View 37
Allergen immunotherapy and asthma 36
Special Issues for Coronavirus Disease 2019 in Children and Adolescents 36
Antihistamines in children and adolescents: A practical update 35
Allergy and asthma in children and adolescents during the COVID outbreak: What we know and how we could prevent allergy and asthma flares 35
Biologic Use in Allergic and Asthmatic Children and Adolescents during the COVID-19 Pandemic 35
Periostin, type 2 biomarker, is not associated with asthma control grade in asthmatic allergic children 34
Profiles of birch sensitization (Bet v 1, Bet v 2, and Bet v 4) and oral allergy syndrome across Italy 33
COVID-19 in the pediatric population admitted to a tertiary referral hospital in Northern Italy: Preliminary clinical data 33
A polycentric, randomized, parallel-group, study on Lertal®, a multicomponent nutraceutical, as preventive treatment in children with allergic rhinoconjunctivitis: phase II 31
What are the effects of rhinitis on patients with asthma? 31
Allergy and Otitis Media in Clinical Practice 31
Asthma in children and adolescents: The control’asma project 31
Cough Remedies for Children and Adolescents: Current and Future Perspectives 30
New approaches for identifying and testing potential new anti-asthma agents 29
Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic 29
The relevance of symptom perception in the management of severe asthma in adolescents 29
An update on the role of chronic rhinosinusitis with nasal polyps as a co-morbidity in severe asthma 29
The treatment of allergic rhinitis in asthmatic children and adolescents: practical outcomes from the real-world "ControL'Asma" study 29
Tryptophan metabolic pathway and neopterin in asthmatic children in clinical practice 28
Complementary treatment of allergic rhinoconjunctivitis: The role of the nutraceutical lertal® 28
Focus on the cetirizine use in clinical practice: a reappraisal 30  years later 27
Personalized therapies for the treatment of allergic rhinitis 27
The psycho-social effects of COVID-19 on Italian adolescents' attitudes and behaviors 27
Pragmatic Markers in the Management of Asthma: A Real-World-Based Approach 27
Foreword 27
Anxiety and depression in adolescents with asthma and in their parents: A study in clinical practice 26
Allergic rhinoconjunctivitis: Pathophysiological mechanism and new therapeutic approach 26
Can an otorhinolaryngological visit induce the suspect of allergic rhinitis in children? 23
Lertal®, a multicomponent nutraceutical, could reduce the use of antihistamines in children with allergic rhinoconjunctivitis 23
The clinical relevance of molecular diagnosis in children allergic to grass pollen and treated with allergen immunotherapy 22
The Measurement of Asthma and Allergic Rhinitis Control in Children and Adolescents 21
Vitamin D3 in children with allergic asthma in clinical practice 20
Children and adolescents with allergy and/or asthma seem to be protected from coronavirus disease 2019 20
The practical clinical relevance of rhinitis classification in children with asthma: outcomes of the “ControL'Asma” study 19
COVID-19 in Italy: The Point of View of the Italian Society of Pediatric Allergy and Immunology-COVID-19 Commission 19
Cetirizine use in childhood: An update of a friendly 30-year drug 17
Serum Aspergillus-specific IgE, IgG and IgG4 immunoglobulins assessment in the work-up of Invasive Pulmonary Aspergillosis: a prospective cohort study 16
Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019 16
Small airways in children with allergic rhinoconjunctivitis: The potential role of a multicomponent nutraceutical 14
The relevance of symptom perception in the management of severe asthma in adolescents 14
Respiratory infections in allergic children: The preventive role of a multicomponent nutraceutical 13
Serum Aspergillus-specific IgE, IgG and IgG4 immunoglobulins assessment in the work-up of invasive pulmonary aspergillosis: a prospective cohort study 12
Letters to the Editor 11
To prevent the allergic disease: The dream of the allergist 10
null 1
Totale 1.934
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.277
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.277
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 0 0 4
2019/2020245 49 103 0 5 9 10 1 16 5 33 14 0
2020/2021145 0 34 4 16 7 13 5 16 3 8 6 33
2021/2022282 1 2 12 6 10 18 5 17 11 11 41 148
2022/2023828 97 49 8 74 52 85 0 39 382 8 27 7
2023/2024402 45 58 39 39 35 106 22 30 3 25 0 0
Totale 1.934